0001555280-14-000146.txt : 20140318 0001555280-14-000146.hdr.sgml : 20140318 20140318060617 ACCESSION NUMBER: 0001555280-14-000146 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140314 FILED AS OF DATE: 20140318 DATE AS OF CHANGE: 20140318 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zoetis Inc. CENTRAL INDEX KEY: 0001555280 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 460696167 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: 973-822-7000 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alaix Juan Ramon CENTRAL INDEX KEY: 0001567824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35797 FILM NUMBER: 14699228 MAIL ADDRESS: STREET 1: C/O ZOETIS INC. STREET 2: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07940 4 1 wf-form4_139513716489514.xml FORM 4 X0306 4 2014-03-14 0 0001555280 Zoetis Inc. ZTS 0001567824 Alaix Juan Ramon C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 1 1 0 0 Chief Executive Officer Phantom Stock Unit 2014-03-14 4 A 0 3467.2304 9.46 A Common Stock 1114.8878 5686.1847 D These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments. /s/ Katherine H. Walden, as Attorney-in-Fact 2014-03-18